
Sign up to save your podcasts
Or


(Bloomberg) -- Intralinks doesn't own a crystal ball, yet the company says its proprietary technology comes close to predicting the future for mergers and acquisitions. Companies use Intralinks to conduct due diligence on potential M&A targets. That means Intralinks has information on what sort of deals are coming about six months before they're announced. Intralinks' Matt Porzio joins Alex Sherman to spill the beans on what kind of deals we'll see in the first half of 2016. Plus, Bloomberg's Aaron Kirchfeld helped break the news on China National Chemical Corp.'s revised bid to acquire Swiss pesticide-maker Syngenta, valued at more than $35 billion. He explains why that deal -- or one between Syngenta and Monsanto Co. -- will probably happen in the coming weeks.
See omnystudio.com/listener for privacy information.
By Bloomberg4.3
7272 ratings
(Bloomberg) -- Intralinks doesn't own a crystal ball, yet the company says its proprietary technology comes close to predicting the future for mergers and acquisitions. Companies use Intralinks to conduct due diligence on potential M&A targets. That means Intralinks has information on what sort of deals are coming about six months before they're announced. Intralinks' Matt Porzio joins Alex Sherman to spill the beans on what kind of deals we'll see in the first half of 2016. Plus, Bloomberg's Aaron Kirchfeld helped break the news on China National Chemical Corp.'s revised bid to acquire Swiss pesticide-maker Syngenta, valued at more than $35 billion. He explains why that deal -- or one between Syngenta and Monsanto Co. -- will probably happen in the coming weeks.
See omnystudio.com/listener for privacy information.

406 Listeners

1,172 Listeners

2,177 Listeners

1,957 Listeners

383 Listeners

417 Listeners

354 Listeners

194 Listeners

61 Listeners

66 Listeners